Bluegrass Allergy Research
illustration of an MRI showing lungs
GS-2304

Asthma Study

Participants will be treated with either mepolizumab (Nucala) or benralizumab (Fasenra) or with an investigational drug. You will be compensated $1,054 for your time and travel.

How Do I Participate?

Check the requirements listed below to determine if you are eligible to participate in this study. If you meet the requirements, apply to participate using the link below. If this study is not a fit for you, see our other studies for additional participation opportunities. 

Requirements:

  • Must be 12 years old or older
  • Must have a diagnosis of asthma for at least 2 years
  • Must have been using mepolizumab (Nucala) or benralizumab (Fasenra) for the past 2 years
  • Must be using an inhaled corticosteroid and an additional controller medication
  • Must be able to make scheduled visits to our medical research office at:

    171 N. Eagle Creek Drive, Suite #102
    Lexington, KY 40509

a question mark cut out of paper

Have Questions?

If you have any questions about this clinical trial or eligibility, we would be glad to help. Call us at 859-303-7191 to speak with a member of our research team. You can also find answers on our frequently asked questions page.

Participate With Confidence

See why Bluegrass Allergy Research is a great place to participate in a clinical trial.